Publications (202) Juan José Lasarte Sagastibelza publications

filter_list

2025

  1. Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML

    Molecular Therapy Oncology, Vol. 33, Núm. 1

  2. Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice

    Acta Pharmacologica Sinica, Vol. 46, Núm. 1, pp. 171-183

  3. Impact of medication use on olfactory performance in older adults

    Frontiers in Public Health, Vol. 13

  4. Optimizing protocols for human regulatory T isolation, expansion, and characterization

    Methods in Cell Biology (Academic Press Inc.), pp. 59-77

  5. Phosphatidylserine as a tumor target for CAR-T cell therapy

    Journal for ImmunoTherapy of Cancer, Vol. 13, Núm. 2

  6. Targeting PD-1+ T cells with small-format immunocytokines enhances IL-12 antitumor activity

    Molecular Therapy, Vol. 33, Núm. 1, pp. 297-316

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  3. DNA electroporation in a vacuum: A “shocking” innovation for vaccines

    Molecular Therapy Nucleic Acids

  4. Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting Glypican 3 effectively control human hepatocellular carcinoma in mice

    Hepatology

  5. Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma

    Blood Advances, Vol. 8, Núm. 21, pp. 5479-5492

  6. Quantitative Approach to Explore Regulatory T Cell Activity in Immuno-Oncology

    Pharmaceutics, Vol. 16, Núm. 11

  7. Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model

    Journal for immunotherapy of cancer, Vol. 12, Núm. 7

  8. The immune system: uncharted pathways between senses and the brain

    Neural Regeneration Research, Vol. 19, Núm. 6, pp. 1173-1174

2023

  1. Bases celulares de la respuesta inmunitaria

    Biología celular biomédica (Elsevier), pp. 408-435

  2. Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies

    Frontiers in Immunology, Vol. 13

  3. Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies(Front. Immunol., (2023), 13, (1044025), 10.3389/fimmu.2022.1044025)

    Frontiers in Immunology

  4. FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma

    Molecular Therapy, Vol. 31, Núm. 1, pp. 48-65

  5. Improvement of cognitive function in wild-type and Alzheimer´s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells

    Frontiers in Immunology, Vol. 14

  6. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses

    Cancer Letters, Vol. 561